Anthropic Launches Claude Science for Labs, Pharma
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Anthropic announced Claude Science at a launch event in San Francisco on Tuesday, an application optimizing its large language model for scientific laboratories and pharma research operations.
- Dario Amodei, Anthropic's CEO, said humans have until now tackled biology's complexity only with their minds, positioning AI as a potential "general purpose technology" for the field.
- Amodei compared biology to code, acknowledging it is "not as simple or clean" but arguing AI can be just as powerful a tool for making sense of it.
- Amodei conceded uncertainty about the product's viability, stating plainly: "We don't know for sure if that's going to work out," while pointing to "the beginnings" of progress.
Why it matters: Claude Science puts Anthropic directly into the toolkit that pharma researchers and lab scientists rely on, a high-value vertical where AI competitors are also racing to embed themselves. Amodei's hedged framing — acknowledging the bet might not pay off — signals this is an early, exploratory product rather than a proven revenue driver.
